Spinal cord stimulation system lead body may be exposed to stress at the anchor site. This may result in high impedance measurements or lead fractures, which may lead to inadequate stimulation, additional intervention, including lead explant and replacement.
Source facts
Action
On 6/17/2026, removal notices were mailed and emailed to customers informing them of the following:
1) Stop further use or distribution and segregate affected product.
2) Complete and return the Reply Verification Tracking Form via email to BSCFieldActionCenter@bsci.com
3) Return affected devices to firm.
4) Share this communication with any healthcare professionals in your facility that use the product and with any other organization to which these systems may have been transferred.
Report any adverse events or quality concerns associated with use of these devices to firm via email at BSCComplaints@bsci.com
This removal of unused Infinion CX Leads is part of the planned transition to the next generation lead (Infinion Pro).
Initiated
2026-06-17
Root cause
Device Design
Distribution
US: NY.
OUS: Canada, Portugal, Spain, France, Netherlands, Great Britain, Italy, Israel, Serbia, Greece, Germany, United Arab Emirates, Ireland, Hungary, Czech Republic, Brazil, Colombia, Argentina
Recall number
Z-2879-2026
Recall status
Open, Classified
CDRH record ID
220311
FDA classified
2026-08-05
Recall event number
98974
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.
Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.